A meta-analysis was performed to assess the accuracy of contrast-enhanced endoscopic ultrasonography (EUS) for distinguishing pancreatic adenocarcinoma from other pancreatic masses. 12 studies were included in the analysis, involving 1,139 patients. The pooled sensitivity and specificity of contrast-enhanced EUS was 94% and 89%, respectively. The authors of the meta-analysis conclude that this technique could be useful in clinical practice.
ORIGINAL RESEARCH PAPER
Gong, T.-T. et al. Contrast-enhanced EUS for differential diagnosis of pancreatic mass lesions: a meta-analysis. Gastrointest. Endosc. doi:10.1016/j.gie.2012.02.051
Rights and permissions
About this article
Cite this article
Distinguishing pancreatic adenocarcinoma from other pancreatic mass lesions. Nat Rev Gastroenterol Hepatol 9, 426 (2012). https://doi.org/10.1038/nrgastro.2012.131
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2012.131